University of Nebraska Medical Center

7 Medical Centers Join Pulmonary Fibrosis Foundation's Care Center Network

Retrieved on: 
Wednesday, December 7, 2022
Linda, Chapel Hill, Rockcastle Regional Hospital and Respiratory Care Center, Quality, Doctor of Philosophy, Patient, RN, University of California, San Diego, University of Nebraska Medical Center, Pulmonology, Research, Nebraska Medicine, MSN, CCN, Health care, COVID-19, Rheumatology, Pathology, Caregiver, Pulmonary fibrosis, Radiology, University, Hospital, PFF, Loma Linda, California, NP, University of North Carolina at Greensboro, Loma Linda University, Rush University Medical Center, Medical college, Medicine, Harbor

CHICAGO, Dec. 7, 2022 /PRNewswire/ -- More than 250,000 Americans living with pulmonary fibrosis now have access to expert treatment at seven medical centers that have been added to the Pulmonary Fibrosis Foundation's (PFF) Care Center Network (CCN). With the new sites, the PFF Care Center Network totals 81 medical facilities in 35 states across the U.S.

Key Points: 
  • CHICAGO, Dec. 7, 2022 /PRNewswire/ -- More than 250,000 Americans living with pulmonary fibrosis now have access to expert treatment at seven medical centers that have been added to the Pulmonary Fibrosis Foundation's (PFF) Care Center Network (CCN).
  • This year we resumed our expansion plans and added a total of 13 leading pulmonology centers to our network."
  • The newest medical centers to receive the Care Center Network designation are:
    Corewell Health East (Royal Oak, Mich.) Coordinator: Heather Whitt, RN
    Loma Linda University (Loma Linda, Calif.) Coordinator: Jeanette Merrill-Henry
    University of California San Diego (San Diego, Calif.) Coordinator: Nadine Basbas
    University of Nebraska Medical Center (Omaha, Neb.)
  • The 81 sites now operating in the PFF Care Center Network are:

Phoenix Children's Names Leading Surgeon-Scientist Matthew Halanski, MD, Division Chief of Orthopedics and Sports Medicine

Retrieved on: 
Tuesday, November 29, 2022
Dignity, Pediatrics, Human services, Elective surgery, Wayne State University, Heel, Mercy Gilbert Medical Center, Hospital, University, Trauma, R21, Sports medicine, Joint, Medical Center, University of Nebraska Medical Center, U.S. News & World Report, United States Department of Health and Human Services, Starship Hospital, Augustus A. Bird, Workforce, MD, Rehabilitation, Phoenix Children's Hospital, Child, Wayne, Michigan State University, NIH, Research, Muscle, Quality of life, Deformity, News, University of Wisconsin–Madison, Division, Nebraska Medicine, Dentistry, Medicine, Orthopedic surgery

PHOENIX, Nov. 29, 2022 /PRNewswire/ -- Phoenix Children's , one of the fastest-growing pediatric healthcare systems in the country, today announced the appointment of internationally renowned surgeon-scientist Matthew Halanski, MD, as Division Chief of Orthopedics and Sports Medicine.

Key Points: 
  • PHOENIX, Nov. 29, 2022 /PRNewswire/ -- Phoenix Children's , one of the fastest-growing pediatric healthcare systems in the country, today announced the appointment of internationally renowned surgeon-scientist Matthew Halanski, MD, as Division Chief of Orthopedics and Sports Medicine.
  • Dr. Halanski will lead the Herbert J. Louis Center for Orthopedics and Sports Medicine at Phoenix Children's .He is a prolific surgeon, researcher and professor in the fields of pediatric orthopedics and sports medicine .
  • Indeed, the Herbert J. Louis Center for Orthopedics and Sports Medicine regularly receives high rankings in U.S. News & World Report's "Best Children's Hospital" list.
  • Phoenix Children's Care Network includes more than 1,175 pediatric primary care providers and specialists who deliver care across more than 75 subspecialties.

Arable Wins Fast Company’s Next Big Things in Tech Award

Retrieved on: 
Thursday, November 17, 2022
Technology, Environmental Issues, Environmental Health, Agritech, Environment, IOT (Internet of Things), Software, Agriculture, Internet, Natural Resources, Hardware, Green Technology, Data Management, Climate Change, Agriculture, The Nature Conservancy, Arable, Treasury Wine Estates, Food, Bayer, Environment, Machine learning, Weather, World Food Programme, Research, University of Nebraska Medical Center, Intelligence, Fertilisation, Organization, University, Soil, Crop protection, Health, Natural Resources, IOT, Water

Arable , an industry trailblazer whose transformational crop intelligence technology is advancing agriculture around the world, announced today that it won Fast Company magazines Next Big Things in Tech Award in the agriculture category.

Key Points: 
  • Arable , an industry trailblazer whose transformational crop intelligence technology is advancing agriculture around the world, announced today that it won Fast Company magazines Next Big Things in Tech Award in the agriculture category.
  • This award honors real-world technology breakthroughs that promise to shape the future in the next five years.
  • Were honored to receive this recognition from Fast Company, as the need for new technologies that can improve the productivity, sustainability and profitability of farming has never been greater," said Jim Ethington, CEO of Arable.
  • Arable helps customers in more than 30 countries optimize water use, crop protection, fertilization, field work, research trials, food supply chains and sustainability initiatives.

Aimbridge Hospitality Welcomes Patrick Volz as Chief Operating Officer, Global Operations

Retrieved on: 
Tuesday, November 15, 2022
Hilton Worldwide, Global Operations, Marriott International, BRE, ROI, E-commerce, Blackstone, Aimbridge Hospitality, University, National Restaurant Association, Master of Business Administration, Wharton School of the University of Pennsylvania, Industry, View, F&B, Partner, Forecasting, Full service, Multimedia, CFO, Volz, University of Nebraska Medical Center, Business administration, Selective Service Act of 1917, Management, Hotel

PLANO, Texas, Nov. 15, 2022 /PRNewswire/ -- Aimbridge Hospitality, a leading global hospitality company, today introduced hospitality industry veteran Patrick Volz as its Chief Operating Officer, Global Operations. Volz represents the company's continued investment in assembling a team of proven industry talent and will contribute to Aimbridge Hospitality's current growth trajectory through strategic development and operational expertise.

Key Points: 
  • PLANO, Texas, Nov. 15, 2022 /PRNewswire/ -- Aimbridge Hospitality, a leading global hospitality company, today introduced hospitality industry veteran Patrick Volz as its Chief Operating Officer, Global Operations.
  • He will report to Mark Tamis, Aimbridge President, Global Operations.
  • Tamis will continue to oversee the six Divisional Presidents announced earlier this year as part of Aimbridge Hospitality's new operating divisional structure, which bolsters the advantages of working with Aimbridge Hospitality at scale.
  • Aimbridge Hospitality is a leading, global hospitality company with a growing hotel portfolio representing more than 1,500 properties in 50 states and over 20 countries, inclusive of pipeline.

Global Precision Medicine Market Report 2022: Collaborations & Partnerships Between Major Players Fuel Sector - ResearchAndMarkets.com

Retrieved on: 
Wednesday, November 9, 2022
Biotechnology, Pharmaceutical, Health, Oncology, AstraZeneca, Precision medicine, Region, Biology, Adoption, Diagnosis, Biotechnology, Thermo Fisher Scientific, Biomarker, Cancer, Disease, Disorder, University of Nebraska Medical Center, University, Patient, PMSC, Technology, Population health, Nebraska Medicine, Fine chemical, Pharmaceutical industry

The "Global Precision Medicine Market by Technology, Application, and Region - Size, Share, Outlook, and Opportunity Analysis 2019-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Precision Medicine Market by Technology, Application, and Region - Size, Share, Outlook, and Opportunity Analysis 2019-2027" report has been added to ResearchAndMarkets.com's offering.
  • Precision medicine guides disease diagnosis, treatment, and prevention of cancer, hereditary diseases, and other disorders based on an individual's unique clinical, molecular, and lifestyle information.
  • Clinicians employ a combination of genomic data, health records, lab tests, and other patient data to help personalise therapy in precision medicine.
  • The increasing adoption of inorganic strategies such as collaborations and partnerships by the key players in the market is expected to drive the global precision medicine market over the forecast period.

Innovate Conference Spotlights Nebraska’s Bioscience Ecosystem

Retrieved on: 
Thursday, October 20, 2022
Nebraska Medicine, Growth, Conference, Technology transfer, UNMC, Research, University of Nebraska Medical Center, Omaha–Council Bluffs metropolitan area, University, Economic development, Health, CEO, Greater Omaha Chamber of Commerce, Leadership, GLOBE, VIP, Omaha Public Power District, Uneme language, Public health, Car rental, Management

The Innovate Conference featured a keynote from Dr. Jim Linder, CEO of Nebraska Medicine and founder of Linseed Capital.

Key Points: 
  • The Innovate Conference featured a keynote from Dr. Jim Linder, CEO of Nebraska Medicine and founder of Linseed Capital.
  • The Innovate Nebraska conference was a great opportunity for us to connect the amazing breakthroughs being made in Nebraska with business leaders who can help bring those innovations to market and grow our local medtech ecosystem.
  • Innovate Nebraska led into the Bio Nebraska annual meeting, where Governor Pete Ricketts presented the Governors Bioscience Award.
  • Earlier this month, Governor Ricketts officially proclaimed the month of October as Bioscience Month in Nebraska.

Eagle Pharmaceuticals Announces Submission of Investigational New Drug Application to U.S. Food and Drug Administration for CAL02, a Novel First-in-Class Broad-Spectrum Anti-Virulence Agent for the Treatment of Severe Community-Acquired Bacterial Pneumoni

Retrieved on: 
Wednesday, October 12, 2022
IND, Eagle, University, European Medicines Agency, Patent, Phrase, Food and Drug Administration Safety and Innovation Act, Nebraska Medicine, Failure, Genta (company), Biomarker, University of Nebraska Medical Center, Infection, The New England Journal of Medicine, Jean-Louis Vincent, Streptococcus, Pneumonia, Regulation of tobacco by the U.S. Food and Drug Administration, Drug development, MPH, Private Securities Litigation Reform Act, Company, P, S, GLOBE, FDA, Hospital, Annual report, Critical care, Research, Security (finance), U.S. Securities and Exchange Commission, CNS, Death, Compliance, Physician, Disease, Community-acquired pneumonia, SEC, Finelli, Patient, Nasdaq, Food, Tariff, Safety, Bronchopneumonia, Forward-looking statement, COVID-19, Pharmaceutical industry, Santu Mofokeng, Medicine, MD

WOODCLIFF LAKE, N.J., Oct. 12, 2022 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) announced today that it has submitted an investigational new drug (“IND”) application to the U.S. Food and Drug Administration (“FDA”) for CAL02, a novel first-in-class broad-spectrum anti-virulence agent for the treatment of severe community-acquired bacterial pneumonia (“SCABP”).

Key Points: 
  • CAL02 is a very interesting agent with a unique mechanism of action.
  • CAL02 has the potential to shift the treatment paradigm for patients with severe community-acquired pneumonia, a leading cause of death worldwide.
  • In addition, Eagle believes a CAL02 new drug application for the treatment of SCABP may qualify for priority review.
  • 2 Jain, S., Self, W. H., Wunderink, R. G., Fakhran, S., Balk, R., Bramley, A. M., ... & Finelli, L. (2015).

Berenberg Continues U.S. Philanthropic Efforts at Annual Charity Golf Event in New York

Retrieved on: 
Thursday, October 6, 2022
Pancreatic cancer, Nebraska Medicine, Disease, UNMC, Research, University of Nebraska Medical Center, Partnership, History, University, NEW, Drug discovery, Player of the year award, PGA Tour, Name, Biomarker, Pharmaceutical industry, Bank, Berenberg family

NEW YORK, October 06, 2022  /PRNewswire-PRWeb/ -- Berenberg, the world's second oldest bank, utilized their presence in New York to host professional golfers and clients for the Berenberg Invitational to raise invaluable funds for charitable causes.

Key Points: 
  • NEW YORK, October 06, 2022 /PRNewswire-PRWeb/ -- Berenberg , the world's second oldest bank, utilized their presence in New York to host professional golfers and clients for the Berenberg Invitational to raise invaluable funds for charitable causes.
  • This year's Berenberg Invitational at GlenArbor Golf Club raised $750,000 for pancreatic cancer research at the University of Nebraska Medical Center and Nebraska Medicine, bringing Berenberg's combined donation over two tournaments to $1,450,000.
  • Our focus on charitable efforts will never waiver, and our Berenberg Invitational would not be possible without the generous contributions made by both our clients and an incredible field of participants."
  • Berenberg has held an annual charity golf event in New York featuring legends of the game for nearly a decade.

The University of Nebraska System Deploys YuJa Enterprise Video Platform Across Four Campuses to Serve More Than 50,000 Students

Retrieved on: 
Friday, September 30, 2022
Education, Technology, VoIP, Audio, Video, Software, University, University, Education, Nebraska Medicine, Yuzu, Canvas, Roposo, Organization, Inc., Learning, Educational technology, Industry, University of Nebraska system, Government, Student, Inside Higher Ed, University of Nebraska–Lincoln, Research, Online video platform, Silicon, University of Nebraska Medical Center, Car rental, Tutoring

The University of Nebraska System has deployed the YuJa Enterprise Video Platform across its four campuses, including the University of Nebraska-Lincoln, the University of Nebraska at Omaha, the University of Nebraska Medical Center, and the University of Nebraska at Kearney.

Key Points: 
  • The University of Nebraska System has deployed the YuJa Enterprise Video Platform across its four campuses, including the University of Nebraska-Lincoln, the University of Nebraska at Omaha, the University of Nebraska Medical Center, and the University of Nebraska at Kearney.
  • The institution was seeking a replacement for VidGrid, its former video enterprise learning and development platform, which is phasing out its education platform.
  • In addition to the Video Platform, the University of Nebraska System added YuJa Pro Captioning, YuJas human captioning solution, to help meet regulatory and industry accessibility regulations.
  • The system is comprised of four campuses: the University of Nebraska-Lincoln, the University of Nebraska at Omaha, the University of Nebraska Medical Center, and the University of Nebraska at Kearney.

Health Catalyst Announces New Leadership Assignments in Support of Strategic Focus Areas

Retrieved on: 
Wednesday, September 7, 2022
Partnership, University, Technology, Advertising, Information system, Communications officer, Engineering, Editing, Associate, Mass communication, SALT, Senior, Albany Medical Center, HCAT, Empire State College, Foundation, University of Nebraska Medical Center, Montana State University Billings, Archaeology, Leadership, Trauma Center, Moses Austin, Triage, Population health, Senior advisor, Bachelor of Arts in Applied Psychology, Growth, Acquisition, Management, Science, Journalism, Sociology, Marketing

SALT LAKE CITY, Sept. 7, 2022 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced three new leadership assignments in support of its strategic focus areas moving forward. These strategic focus areas center around strengthening and deepening existing client relationships to enable greater success in realizing massive, measurable, data-informed improvement while continuing to add new client relationships.

Key Points: 
  • Announces Appointments of Kevin Freeman as Chief Growth Officer, Tarah Neujahr Bryan as Chief Marketing Officer, and Dave Ross as Chief Technology Officer
    SALT LAKE CITY, Sept. 7, 2022 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced three new leadership assignments in support of its strategic focus areas moving forward.
  • These strategic focus areas center around strengthening and deepening existing client relationships to enable greater success in realizing massive, measurable, data-informed improvementwhile continuing to add new client relationships.
  • Kevin Freeman came to Health Catalyst in 2020 as part of the Vitalware acquisition, bringing 20+ years of healthcare IT growth leadership experience including publicly traded, private equity, and venture-capital-backed companies.
  • Health Catalyst has also named Dave Ross, current Associate Chief Technology Officer, as Chief Technology Officer, also effective September 7, 2022.